成人颅内感染性疾病脑脊液检测指标变化的研究

目的观察成人颅内感染性疾病患者脑脊液中白介素-6(interleukin-6,IL-6)、超敏C反应蛋白(high sensitive C-reactive protein,hs-CRP)、降钙素原(procalcitonin,PCT)、乳酸脱氢酶(lactic dehydrogenase,LDH)、腺苷脱氨酶(adenosine deaminase,ADA)、胆碱酯酶(cholinesterase,CHE)、谷草转氨酶(glutamic oxalacetic transaminase,AST/GOT)水平的变化,并探讨其临床意义。方法选取郑州大学第二附属医院2015-01—2018-06收治的120例患者,A组为30例化脓性脑膜炎患者,B组为28例病毒性脑膜炎患者,C组为22例结核性脑膜炎患者,D组为40例无颅内感染的患者。检测脑脊液IL-6、hs-CRP、PCT、LDH、ADA、CHE、AST水平,比较4组检测指标。结果 A、B、C组分别与D组相比,A组脑脊液hs-CRP、PCT、ADA水平明显高于D组,差异有统计学意义(P0. 05); B组脑脊液hs-CRP、PCT、ADA水平与D组相比,差异无统计学意义(P 0. 05); C组脑脊液ADA水平明显高于D组,差异有统计学意义(P0. 05); PCT、hs-CRP水平与D组相比,差异无统计学意义(P 0. 05); A、B、C组IL-6、LDH、CHE、AST水平均明显高于D组,差异有统计学意义(P0. 05)。结论成人化脓性脑膜炎患者脑脊液中IL-6、hs-CRP、PCT、LDH、ADA、CHE、AST水平明显升高,对化脓性脑膜炎患者具有较高的早期诊断价值; ADA可作为结核性脑膜炎的鉴别诊断指标。     

病毒性脑炎并发心肌损害患儿血清cTnT与心肌酶的变化及意义

目的观察病毒性脑炎并发心肌损害患儿血清cTnT及心肌酶的变化。方法 56例病毒性脑炎并发心肌损害患儿为心肌损害组,40例病毒性脑炎患儿为脑炎组,50例健康儿童为对照组,对3组受试者血清LDH、CK、CK-MB、AST及cTnT进行检测并统计分析。结果心肌损害组血清AST、LDH、CK显著高于脑炎组,脑炎组显著高于对照组,差异均有统计学意义(P0.05)。心肌损害组CK-MB及cTnT水平明显高于其他2组(P0.05)。结论血清心肌酶尤其CM-MB与cTnT对病毒性脑炎并发心肌损害患儿具有较高的早期诊断价值,临床应给予高度重视,以便尽早诊治,以免延误治疗。     

成人颅内感染血清心肌酶和脑脊液乳酸脱氢酶的改变及其临床意义

目的　观察成人颅内感染急性期血清心肌酶和脑脊液 (CSF)乳酸脱氢酶 (LDH)的改变及其临床意义。方法　用酶速率法测定颅内感染患者 (发病 7天内 )血清心肌酶 [天门冬氨酸氨基转移酶 (AST)、LDH、α 羟丁酸脱氢酶 (α HBDH)、肌酸激酶 (CK)、肌酸激酶心型 (CK MB) ],并行腰穿取CSF检测LDH、白细胞数、蛋白定量等。结果　颅内感染组 [病毒性脑炎 (病脑 ) 31例 ,结核性脑膜炎 (结脑 ) 11例 ,其它颅内感染 4例 ]血清心肌酶及CSFLDH均显著高于对照组 (P <0 0 5～ 0 0 1) ;病脑组与结脑组的血清心肌酶比较无显著差异 (P >0 0 5 ) ;结脑组CSFLDH明显高于病脑组 (P <0 0 1) ;CSF中LDH与血清LDH、CSF白细胞数和蛋白均无相关性(r=0 16 9,P >0 2 0 ;r=0 2 83,P >0 0 5 ;r=0 2 76 ,P >0 0 5 )。结论　成人颅内感染急性期存在明显的血清心肌酶及CSFLDH增高 ,检测血清心肌酶和CSFLDH有助于颅内感染的早期诊断和鉴别诊断     

脑梗死患者血清AST CK CK-MB LDH及Fbg水平与TOAST分型的关系

目的探讨脑梗死患者血清AST、CK、CK-MB、LDH及Fbg水平与TOAST分型的关系。方法分析2012-01—2014-01我院神经内科收治的125例脑梗死患者的临床资料。结果 LAA组、CE组、SAO组患者AST、CK、CK-MB、LDH水平均明显比OC组、UE组高(P0.05);5组患者补体C3水平差异均无统计学意义(P0.05),但LAA组、CE组、SAO组Fbg水平均明显比OC组、UE组高(P0.05)。结论脑梗死患者血清AST、CK、CK-MB、LDH及Fbg水平与TOAST分型关系密切。     

急性脑血管病患者心肌酶谱变化及临床意义

目的观察急性脑血管病时心肌酶的变化。方法对150例急性脑血管病患者和50例健康体检者静脉血清AST、LDH、CK、-αHBDH于发病2d内进行检测。结果血清AST、LDH、CK、-αHBDH、CK-MB水平急性脑血管病组明显高于对照组(P<0.01),而脑出血组与脑梗死组患者之间心肌酶水平无明显差异(P>0.05),有意识障碍与无意识障碍患者血清AST、LDH、α-HBDH有显著性差异(P<0.05),CK、CK-MB有非常显著性差异(P<0.01)。结论急性脑血管病患者心肌酶谱的变化其程度与病变范围及意识障碍程度相一致,与病变的性质无关。     

三种药物对精神分裂症患者心肌酶及心电图异常率的影响

目的探讨氨磺必利、氯氮平及阿立哌唑对精神分裂症患者心肌酶及心电图异常率的影响。方法选取精神分裂症患者150例,以随机数字表法分为A组(50例)、B组(50例)及C组(50例),分别采用氨磺必利、氯氮平及阿立哌唑治疗;比较三组患者治疗前后谷草转氨酶(glutamic-oxalacetic transaminase,AST)、肌酸激酶(creatine kinase,CK)、肌酸激酶同工酶(creatine kinase isoenzyme,CK-MB)、乳酸脱氢酶(lactate dehydrogenase,LDH)、α-羟丁酸脱氢酶(alphahydroxybutyric dehydrogenase,α-HBDH)及随访心电图异常率等。结果三组患者治疗前后AST、CK-MB及LDH比较差异无统计学意义(P0.05);三组患者治疗后CK和α-HBDH水平显著高于治疗前(P0.05);A、C组患者随访心电图异常率显著低于B组(P0.05);A组和C患者随访心电图异常率比较差异无统计学意义(P0.05)。结论氨磺必利、氯氮平及阿立哌唑治疗精神分裂症均可产生心脏毒性,但氯氮平较氨磺必利、阿立哌唑更易出现心电图异常。     

降钙素原在婴幼儿化脓性脑膜炎早期诊断中的意义

目的探讨降钙素原在婴幼儿化脓性脑膜炎早期诊断中的意义。方法将我院2014-02—2015-10收治的71例脑膜炎患者根据临床诊断分为化脓性脑膜炎患儿36例(观察B组)和病毒性脑膜炎患儿35例(观察A组),选择同期于我院治疗的非感染性疾病患儿35例为对照组,3组患者均予以血清降钙素原、C反应蛋白、白细胞计数检测,对比3种检测方法的诊断价值。结果 3组降钙素原、C反应蛋白阳性率对比具有显著性差异(P0.05),其中观察B组降钙素原阳性率、C反应蛋白阳性率明显高于观察A组、对照组(P0.05);观察B组内,降钙素原检测阳性率明显高于C反应蛋白、白细胞计数(P0.05);3组降钙素原、C反应蛋白、白细胞计数定量检测结果对比差异有统计学意义(P0.05),其中观察B组降钙素原、C反应蛋白、白细胞计数均明显高于观察A组、对照组(P0.05)。结论降钙素原在婴幼儿化脓性脑膜炎早期诊断中的应用价值高,值得推广。     

丙戊酸镁与拉莫三嗪联合治疗儿童癫痫的疗效与安全性分析

目的观察丙戊酸镁与拉莫三嗪联合治疗儿童癫痫的疗效及安全性,以期为儿童癫痫的临床联合用药提供依据。方法收集本院2014-04—2015-08收治的150例癫痫患儿为研究对象,随机分为丙戊酸镁组50例(A组)、拉莫三嗪组50例(B组)与丙戊酸镁联合拉莫三嗪组50例(C组)。统计3组治疗效果与不良反应发生率。结果 (1)C组总有效率明显优于A组和B组,差异有统计学意义(P0.05),A组与B组比较差异无统计学意义(P0.05)。(2)C组药物不良反应发生率明显少A组和B组,差异有统计学意义(P0.05);A组与B组比较差异无统计学意义(P0.05)。结论丙戊酸镁与拉莫三嗪联合治疗儿童癫痫临床疗效显著,安全性较高,值得推广应用。     

阿立哌唑联合奥氮平对老年精神分裂症患者糖脂代谢及心肌酶的影响

目的探讨阿立哌唑联合奥氮平对老年精神分裂症患者糖脂代谢及心肌酶的影响。方法将60例老年精神分裂症患者随机分为观察组和对照组各30例,对照组给予奥氮平治疗,观察组给予阿立哌唑联合奥氮平治疗,治疗12周后,比较两组患者糖脂代谢、心肌酶及临床疗效。结果两组患者各项血液生化指标在治疗前组间差异不明显(P0.05);治疗后,观察组有效率为93.33%,明显高于对照组的73.33%(P0.05);观察组糖脂代谢及心肌酶各指标在治疗前后均无显著差异(P0.05),且空腹血糖(CLU)、总胆固醇(TC)、甘油三脂(TG)、低密度脂蛋白(LDL)均明显低于对照组,高密度脂蛋白(HDL)明显高于对照组(P0.05);血清谷草转氨酶(AST)、乳酸脱氢酶(LDH)、肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)均明显低于对照组(P0.05)。结论阿立哌唑联合奥氮平有助于提高老年精神分裂症患者临床疗效,且对糖脂代谢、心肌酶等影响较小。     

严重脑外伤患者心电图及心肌酶谱改变的临床意义

目的：分析严重颅脑外伤患者心电图及心肌酶谱改变的临床意义。方法将我院2011-08-2013-07收治的颅脑外伤患者86例纳入本研究,根据入院时GCS评分分组。其中GCS评分＞8分者为轻度颅脑损伤（A组）,GCS评分≤8分者为严重颅脑损伤（B组）。对比2组患者心电图、心肌酶谱等方面的差异。结果对比2组心电图检查结果,B组心电图异常率明显高于A组,差异有统计学意义（P＜0·05）。心肌酶谱检查结果B组AST、CK、CKMB、LDH、HBDH等指标明显高于A组,差异有统计学意义（P＜0·05）。结论颅脑外伤患者心电图及心肌酶谱异常改变,与创伤严重程度具有一定的相关性,早期检查心电图和血清心肌酶可辅助判断伤情和预后。     

Treatment with rituximab in patients with polyneuropathy with anti-MAG antibodies

Journal of Neurology -     

Factors associated with satisfaction with care among patients with epilepsy

OBJECTIVE: The purpose of the work described here was to determine those variables associated with satisfaction with care among patients with epilepsy. METHODS: We interviewed patients followed at a tertiary epilepsy center. Predictor variables included age, gender, race, education, income, insurance, seizure frequency, and Quality of Life in Epilepsy-10 inventory (QOLIE-10) results. Target variables were the subscales of the Short Form Patient Satisfaction Questionnaire (PSQ-18). We used univariate analysis to identify those variables significantly associated with the subscales and multiple linear regression to determine those independently significant. RESULTS: The study population comprised 193 patients. Lower education and better QOLIE-10 scores were independently associated with general satisfaction with care. The mental health scale was associated with general satisfaction with care. Lower educational level was the only variable independently associated with patient satisfaction with communication, the financial aspect of care, and time spent with physician. CONCLUSION: Lower educational level and better quality of life are the main variables associated with higher general satisfaction with care among patients with epilepsy.     

Children with ADHD and motor dysfunction compared with children with ADHD only

The purpose of this study was to identify group differences in children with attention-deficit-hyperactivity disorder and motor dysfunction (ADHD-MD) and ADHD only, and to evaluate the medication responsiveness of ADHD-MD. Sixty-three children (49 males and 14 females; mean age 9 years 10 months, SD 2 years 10 months) underwent a triple blind, placebo-controlled crossover study evaluating two dose levels of methylphenidate (0.3 mg/kg and 0.5 mg/kg [corrected], twice daily) and placebo. Forty-nine trials were completed. Nineteen were children with ADHD-MD, 44 had ADHD only. Behavior and functioning were assessed at home and at school. Treatment effects were assessed using the Abbreviated Symptom Questionnaire for Parents and Teachers. Children with ADHD-MD were more likely to have severe ADHD-combined type and other neurodevelopmental and behavioral problems. Both groups of children had a linear dose response to medication (placebo, low, high) and there was no evidence of a group by dose interaction or an overall group effect at home or school. The lack of group effect suggests that these children responded to medication like the other subgroups.